Archive · 20 Sep 2025
Indian Pharma Market Sees Steady Growth in August
The Indian pharma market is doing well, growing about 8% in August 2025.
This growth is because more people are using medicines for long-term conditions like heart problems and diabetes, as well as for respiratory issues and cancer.
Even though the number of products sold has slightly decreased, the industry is still growing.
Experts think the market will keep growing, at around 8-9% in the coming year.
The government is also helping the industry, which is already a big player worldwide.
The Indian Pharmaceutical Market grew by 8.1% in August 2025.
Chronic therapies experienced strong growth, up 12% in August.
Acute therapies saw a 6% increase in August.
GLP-1 therapies sales increased by 97% month-on-month.
Industry is projected to reach USD 130 billion by 2030 and USD 450 billion by 2047.
- Who
- The Indian Pharmaceutical Market.
- What
- Registered an 8.1% growth in August 2025.
- When
- August 2025.
- Where
- India.
- Why
- Fueled by chronic therapies and gains in respiratory and oncology.
- August 2025 Growth
- 8.1%
- FY25 Growth
- 8%
- Chronic Therapies Growth (August)
- 12%
- Acute Therapies Growth (August)
- 6%
- Projected FY26 Growth
- 8-9%
- Industry Global Rank (Volume)
- 3rd
- Industry Global Rank (Value)
- 14th
- Market Projection by 2030
- $130 billion
- Market Projection by 2047
- $450 billion